Capricor Therapeutics Inc (NASDAQ: CAPR) is -1.56% lower on its value in year-to-date trading and has touched a low of $3.52 and a high of $23.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CAPR stock was last observed hovering at around $12.65 in the last trading session, with the day’s gains setting it 0.94%.
Currently trading at $13.59, the stock is -6.51% and -5.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.57 million and changing 7.39% at the moment leaves the stock 22.70% off its SMA200. CAPR registered 190.90% gain for a year compared to 6-month gain of 210.87%.
The stock witnessed a -9.85% loss in the last 1 month and extending the period to 3 months gives it a -30.83%, and is -5.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.29% over the week and 9.97% over the month.
Capricor Therapeutics Inc (CAPR) has around 102 employees, a market worth around $617.70M and $23.23M in sales. Profit margin for the company is -146.86%. Distance from 52-week low is 285.94% and -41.94% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.07%).
with sales reaching $9.87M over the same period.The EPS is expected to shrink by -50.12% this year, but quarterly earnings will post -16.70% year-over-year. Quarterly sales are estimated to shrink -18.35% in year-over-year returns.
The shares outstanding are 40.33M, and float is at 39.98M with Short Float at 20.41%.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.63 million shares valued at $7.77 million. The investor’s holdings represent 5.194 of the CAPR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.55 million shares valued at $7.39 million to account for 4.9401 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.64 million shares representing 2.0462 and valued at over $3.06 million, while MILLENNIUM MANAGEMENT LLC holds 1.5059 of the shares totaling 0.48 million with a market value of $2.29 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Nippon Shinyaku Co Ltd, the company’s 10% Owner. SEC filings show that Nippon Shinyaku Co Ltd bought 2,798,507 shares of the company’s common stock on Sep 20 ’24 at a price of $5.36 per share for a total of $15.0 million. Following the purchase, the insider now owns 7.09 million shares.
